Garcia-Casal Maria N, Peña-Rosas Juan Pablo, De-Regil Luz Maria, Gwirtz Jeffrey A, Pasricha Sant-Rayn
Evidence and Programme Guidance, Department of Nutrition for Health and Development, World Health Organization, Avenue Appia 20, Geneva, Geneva, Switzerland, 1211.
Cochrane Database Syst Rev. 2018 Dec 22;12(12):CD010187. doi: 10.1002/14651858.CD010187.pub2.
Approximately 800 million women and children have anaemia, a condition thought to cause almost 9% of the global burden of years lived with disability. Around half this burden could be amenable to interventions that involve the provision of iron. Maize (corn) is one of the world's most important cereal grains and is cultivated across most of the globe. Several programmes around the world have fortified maize flour and other maize-derived foodstuffs with iron and other vitamins and minerals to combat anaemia and iron deficiency.
To assess the effects of iron fortification of maize flour, corn meal and fortified maize flour products for anaemia and iron status in the general population.
We searched the following international and regional sources in December 2017 and January 2018: Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE; MEDLINE (R) In Process; Embase; Web of Science (both the Social Science Citation Index and the Science Citation Index); CINAHL Ebsco; POPLINE; AGRICOLA (agricola.nal.usda.gov); BIOSIS (ISI); Bibliomap and TRoPHI; IBECS; Scielo; Global Index Medicus - AFRO (includes African Index Medicus); EMRO (includes Index Medicus for the Eastern Mediterranean Region); LILACS; PAHO (Pan American Health Library); WHOLIS (WHO Library); WPRO (includes Western Pacific Region Index Medicus); IMSEAR, Index Medicus for the South-East Asian Region; IndMED, Indian medical journals; and the Native Health Research Database. We searched clinicaltrials.gov and the International Clinical Trials Registry Platform (ICTRP) for any ongoing or planned studies on 17 January 2018 and contacted authors of such studies to obtain further information or eligible data if available.For assistance in identifying ongoing or unpublished studies, we also contacted relevant international organisations and agencies working in food fortification on 9 August 2016.
We included cluster- or individually randomised controlled trials and observational studies. Interventions included (central/industrial) fortification of maize flour or corn meal with iron alone or with other vitamins and minerals and provided to individuals over 2 years of age (including pregnant and lactating women) from any country.
Two review authors independently assessed the eligibility of studies for inclusion, extracted data from included studies and assessed the risk of bias of the included studies. Trial designs with a comparison group were included to assess the effects of interventions. Trial designs without a control or comparison group (uncontrolled before-and-after studies) were included for completeness but were not considered in assessments of the overall effectiveness of interventions or used to draw conclusions regarding the effects of interventions in the review.
Our search yielded 4529 records. After initial screening of titles and abstracts, we reviewed the full text of 75 studies (80 records). We included 5 studies and excluded 70. All the included studies assessed the effects of providing maize products fortified with iron plus other vitamins and minerals versus unfortified maize flour. No studies compared this intervention to no intervention or looked at the relative effect of flour and products fortified with iron alone (without other vitamins and minerals). Three were randomised trials involving 2610 participants, and two were uncontrolled before-and-after studies involving 849 participants.Only three studies contributed data for the meta-analysis and included children aged 2 to 11.9 years and women. Compared to unfortified maize flour, it is uncertain whether fortifying maize flour or corn meal with iron and other vitamins and minerals has any effect on anaemia (risk ratio (RR) 0.90, 95% confidence interval (CI) 0.58 to 1.40; 2 studies; 1027 participants; very low-certainty evidence), or on the risk of iron deficiency (RR 0.75, 95% CI 0.49 to 1.15; 2 studies; 1102 participants; very low-certainty evidence), haemoglobin concentration (mean difference (MD) 1.25 g/L, 95% CI -2.36 to 4.86 g/L; 3 studies; 1144 participants; very low-certainty evidence) or ferritin concentrations (MD 0.48 µg/L, 95% CI -0.37 to 1.33 µg/L; 1 study; 584 participants; very low-certainty evidence).None of the studies reported on any adverse effects. We judged the certainty of the evidence to be very low based on GRADE, so we are uncertain whether the results reflect the true effect of the intervention. We downgraded evidence due to high risk of selection bias and unclear risk of performance bias in one of two included studies, high heterogeneity and wide CIs crossing the line of no effect for anaemia prevalence and haemoglobin concentration.
AUTHORS' CONCLUSIONS: It is uncertain whether fortifying maize flour with iron and other vitamins and minerals reduces the risk of anaemia or iron deficiency in children aged over 2 years or in adults. Moreover, the evidence is too uncertain to conclude whether iron-fortified maize flour, corn meal or fortified maize flour products have any effect on reducing the risk of anaemia or on improving haemoglobin concentration in the population.We are uncertain whether fortification of maize flour with iron reduces anaemia among the general population, as the certainty of the evidence is very low. No studies reported on any adverse effects.Public organisations funded three of the five included studies, while the private sector gave grants to universities to perform the other two. The presence of industry funding for some of these trials did not appear to positively influence results from these studies.The reduced number of studies, including only two age groups (children and women of reproductive age), as well as the limited number of comparisons (only one out of the four planned) constitute the main limitations of this review.
约8亿妇女和儿童患有贫血症,该病症被认为导致了全球近9%的残疾生存年负担。其中约一半的负担可通过提供铁剂的干预措施来缓解。玉米是世界上最重要的谷物之一,在全球大部分地区都有种植。世界各地的多个项目已在玉米粉和其他玉米衍生食品中强化了铁及其他维生素和矿物质,以对抗贫血和缺铁。
评估玉米粉、玉米粗粉及强化玉米粉产品的铁强化对普通人群贫血症及铁状态的影响。
我们于2017年12月和2018年1月检索了以下国际和区域资源:Cochrane对照试验中心注册库(CENTRAL);MEDLINE;MEDLINE(R)在研;Embase;科学引文索引(包括社会科学引文索引和科学引文索引);CINAHL Ebsco;POPLINE;农业联机存取数据库(agricola.nal.usda.gov);BIOSIS(ISI);Bibliomap和TRoPHI;IBECS;Scielo;全球医学索引 - 非洲区域(包括非洲医学索引);东地中海区域办事处(包括东地中海区域医学索引);LILACS;泛美卫生组织(泛美卫生图书馆);世界卫生组织图书馆(WHOLIS);西太平洋区域办事处(包括西太平洋区域医学索引);IMSEAR,东南亚区域医学索引;印度医学文献数据库(IndMED),印度医学期刊;以及原住民健康研究数据库。我们于2018年1月17日在ClinicalTrials.gov和国际临床试验注册平台(ICTRP)上检索了所有正在进行或计划开展的研究,并联系了这些研究的作者以获取更多信息或可用的合格数据。为了协助识别正在进行或未发表的研究,我们还于2016年8月9日联系了从事食品强化工作的相关国际组织和机构。
我们纳入了整群或个体随机对照试验以及观察性研究。干预措施包括(中央/工业)用铁单独或与其他维生素和矿物质对玉米粉或玉米粗粉进行强化,并提供给来自任何国家的2岁以上个体(包括孕妇和哺乳期妇女)。
两位综述作者独立评估纳入研究的合格性,从纳入研究中提取数据,并评估纳入研究的偏倚风险。纳入有比较组的试验设计以评估干预措施的效果。纳入无对照或比较组的试验设计(非对照前后研究)是为了完整性,但在评估干预措施的总体有效性时未予考虑,也未用于得出关于综述中干预措施效果的结论。
我们的检索共获得4529条记录。在对标题和摘要进行初步筛选后,我们审查了75项研究(80条记录)的全文。我们纳入了5项研究,排除了70项。所有纳入研究均评估了提供强化铁及其他维生素和矿物质的玉米产品与未强化玉米粉的效果。没有研究将该干预措施与不干预进行比较,也没有研究观察仅强化铁(不添加其他维生素和矿物质)的面粉和产品的相对效果。三项是随机试验,涉及2610名参与者,两项是无对照前后研究,涉及849名参与者。只有三项研究为荟萃分析提供了数据,纳入了2至11.9岁的儿童和妇女。与未强化玉米粉相比,用铁和其他维生素和矿物质强化玉米粉或玉米粗粉对贫血症(风险比(RR)0.90,95%置信区间(CI)0.58至1.40;2项研究;1027名参与者;极低确定性证据)、缺铁风险(RR 0.75,95% CI 0.49至1.15;2项研究;1102名参与者;极低确定性证据)、血红蛋白浓度(平均差(MD)1.25 g/L,95% CI -2.36至4.86 g/L;3项研究;1144名参与者;极低确定性证据)或铁蛋白浓度(MD 0.48 µg/L,95% CI -0.37至1.33 µg/L;1项研究;584名参与者;极低确定性证据)是否有影响尚不确定。没有研究报告任何不良反应。根据GRADE,我们判断证据的确定性非常低,因此我们不确定结果是否反映了干预措施的真实效果。由于纳入的两项研究之一存在选择偏倚的高风险和执行偏倚的风险不明确、高异质性以及贫血患病率和血红蛋白浓度的宽置信区间跨越无效应线,我们对证据进行了降级。
用铁和其他维生素和矿物质强化玉米粉是否能降低2岁以上儿童或成年人的贫血风险或缺铁风险尚不确定。此外,证据过于不确定,无法得出铁强化玉米粉、玉米粗粉或强化玉米粉产品对降低人群贫血风险或改善血红蛋白浓度是否有任何影响的结论。由于证据的确定性非常低,我们不确定用铁强化玉米粉是否能降低普通人群中的贫血症。没有研究报告任何不良反应。五项纳入研究中有三项由公共组织资助,而私营部门向大学提供资助以开展另外两项研究。这些试验中部分有行业资助的情况似乎并未对这些研究的结果产生积极影响。研究数量减少,仅包括两个年龄组(儿童和育龄妇女),以及比较数量有限(计划的四项中仅一项)构成了本综述的主要局限性。